Postoperative ileus following laparotomy is a common complication after abdominal surgery and involves an inhibition of bowel transit caused by an impairment of motility. For postoperative ileus, some herbal medicines with experiential gastrointestinal effects have been elucidated pharmacologically. One of them, Dai-kenchu-to, is known to increase gastrointestinal motility and improve ileal function.
Postoperative ileus following laparotomy is a common complication after abdominal surgery and involves an inhibition of bowel transit caused by an impairment of motility. For postoperative ileus, some herbal medicines with experiential gastrointestinal effects have been elucidated pharmacologically. One of them, Dai-kenchu-to, is known to increase gastrointestinal motility and improve ileal function.
1) It is thought that the part of the contractile mechanism is mediated by acetylcholine (ACh) release from the ends of cholinergic nerves. 2, 3) Furthermore, these effects are reported to cause significant increases in the levels of brain-gut peptides such as motilin 4) and vasoactive intestinal peptide (VIP) 5) in human plasma.
Ninjin-to is prepared from four crude drugs: Ginseng radix, Glycyrrhizae radix, Atractylodis rhizome, and Zingiberis siccatum rhizoma. This medicine has been used for the treatment of gastroenteritis, esogastritis, gastric atony, gastrectasis, vomiting, and anorexia. Ninjin-to is also reported to enhance gastrointestinal motility, similar to the gastrointestinal prokinetic drugs like cisapride and metoclopramide. 6 ) Moreover, previous study has shown that Ninjin-to not only significantly improved gastrointestinal motility but also showed stronger effects than those of Dai-kenchu-to in a rat model of postoperative ileus. 7) Hence, as well as Daikenchu-to, Ninjin-to may be an effective herbal medicine for postoperative ileus. Naito et al. previously confirmed that Ninjin-to increased the levels of motilin, a powerful inducer of gastrointestinal motor activity and somatostatin, and that it participates in the control of gut motility by exerting both inhibitory and stimulating influences in human plasma. 8) These results indicate that the action of Ninjin-to is closely related to changes in motilin and somatostatin levels in plasma.
Sensory afferent neurons in the gastrointestinal mucosa regulate neuropeptide [calcitonin gene-related peptide (CGRP) and tachykinins (substance P)] levels and play various physiologic roles. CGRP has several potent biological activities, including vasodilation. It is the most powerful vasoactive substance known and it increases mucosal blood flow. 9, 10) CGRP is known to coexist with tachykinins in the population of sensory neurons in humans.
11) Substance P is widely distributed in the central and peripheral nervous system and in the enteroendocrine cells of the gut 12) and it participates in the regulation of gastrointestinal motility, secretion, and blood flow. 13) At present, the underlying mechanisms of Ninjin-to have not been demonstrated. To determine whether the pharmacologic effects of Ninjin-to on the gastrointestine are due to changes in gastrointestinal mucosa regulatory peptide levels, we examined the temporal effects of Ninjin-to on CGRP-like immunoreactive substances (IS) and substance P-IS levels in plasma as measured by a sensitive enzyme immunoassay (EIA) in healthy subjects.
MATERIALS AND METHODS
Materials Ninjin-to (EK-32, lot 01BJ), prepared as a 3.0-g dried powder extract in the proportion: Ginseng radix (3.0 g), Glycyrrhizae radix (3.0 g), Atractylodis rhizoma (3.0 g), Zingiberis siccatum rhizoma (3.0 g), was kindly supplied by Kanebo Co. Ltd. (Tokyo, Japan). A mixture of sucrose and cellulose was used as a placebo. Synthetic human CGRP and its fragment (8-37), substance P, were purchased from the Peptide Institute (Osaka, Japan). Antisera to CGRP were purchased from Biogenesis (Poole, U.K.), and substance P (RA-08-095) from Cambridge Research Biochemicals (Cambridge, U.K.). All other reagents were of analytical reagent grade from commercial sources.
Subjects Five healthy male volunteers (nonsmokers) participated in this study. Each subject received information about the study's scientific purpose, which was approved by the Ethics Committee of Oita Medical University, and gave informed consent. No subject had received any medication for 1 month preceding the test and no stimulator of gastrointestinal motility was administered to any subject during the study.
Study Schedule Ninjin-to or placebo was orally administered as a single dose of 6.0 g with water. Venous blood samples (10 ml) from a forearm vein were taken for EIA of the CGRP and substance P levels. Samples were taken 20, 40, 60, 90, 120, 180, and 240 min after administration of the test substances. All subjects ate lunch at 11:30-12:00 and the study was carried out from 14:00 (2 h after lunch) to 18:00.
Preparation of Plasma Extracts
The blood samples were collected in a chilled tube containing aprotinin (500 KIU/ml) and ethylenediaminetetraacetic acid (EDTA) (1.2 mg/ml). After centrifugation, the plasma samples were diluted with 4% acetic acid (pH 4.0) and loaded onto SepPak C 18 cartridges (Millipore Corp., Milford, U.S.A.), and washed with 4% acetic acid. The peptides in the plasma were eluted with 70% acetonitrile in 0.5% acetic acid (pH 4.0), lyophilized, and reconstituted to 100 ml with the assay buffer and subjected to EIA. For the EIA system, plasma samples were concentrated five-fold with Sep-Pak C 18 cartridges. The recovery of plasma CGRP-IS and substance P-IS was >90% with this extraction procedure.
EIA of CGRP and Substance P EIAs for CGRP- 14) and substance P-IS 15) were performed using a delayed-addition method. Human CGRP (8-37) and substance P were conjugated with b-D-galactosidase (Boehringer Mannheim, Mannheim, Germany) with N-(e-maleimidocaproyloxy)-succimide.
16) The assay was performed using a delayed-addition method, and separation of bound and free antigen was performed on an anti-rabbit IgG (55641) 
RESULTS AND DISCUSSION
Ninjin-to has been used for thousands of years to improve gastrointestinal functions. In recent years, it has been reported that Ninjin-to significantly improves gastrointestinal motility and it may be useful for the treatment of postoperative ileus. 7) Although the underlying mechanisms on Ninjinto remain unclear, studies by Naito et al. have shown that the effects of gastrointestinal motility are mainly regulated by hormonal and neuronal mechanisms, which may be related to brain-gut peptides (mainly motilin and somatostatin). 8) Therefore, in this study, CGRP and substance P, which regulate gastrointestinal motility, were examined to study the effects of Ninjin-to.
The profiles of mean plasma CGRP-IS levels against time in five healthy subjects after a single oral administration of Ninjin-to or placebo are shown in Fig. 1 . The data were compared with each mean value. Ninjin-to caused significant increases in CGRP-IS at 40 and 60 min (36.0Ϯ9.5 pg/ml at 40 min, 100.2Ϯ62.3 pg/ml at 60 min) compared with the response in the placebo group. Figure 2 shows plasma substance P-IS levels after the administration of Ninjin-to. Ninjin-to increased substance P-IS levels at 90 min (48.8Ϯ10.7 pg/ml) compared with the placebo. These results indicate that the action of Ninjin-to may be related to CGRP and substance P.
CGRP has several potent biological activities, including vasodilation, and in the gastric mucosa its vasodilatory effects following stimulated release from the extrinsic sensory innervation is considered to serve as an important protective mechanism for maintaining mucosal integrity. [17] [18] [19] In addition, CGRP is also present in enteric neurons 20) and has a potent effect on gastrointestinal motility and secretion.
21) The localization of CGRP in the small intestine suggests a regulatory role for CGRP in small intestinal function. Previous studies have reported that the intrinsic sensory pathway, which mediates the peristaltic response to mucosal stimulation, utilizes CGRP as a sensory transmitter. 22) Furthermore, CGRP is a potent intestinal vasodilator in conscious dogs and causes increases in the intestinal blood flow.
23) It was reported that intraduodenal administration of Dai-kenchu-to increases intestinal blood flow in a dose-dependent manner that is mainly mediated by CGRP. 24) Interestingly, Ninjin-to contains two of the same herbs as Dai-kenchu-to: Ginseng radix and Zingiberis siccatum rhizoma, both herbal medicines that have been used to improve gastrointestinal functions. In our results, Ninjin-to significantly raised plasma CGRP-IS levels 40 and 60 min after administration in healthy subjects. Accordingly, the mechanisms of Ninjin-to, as well as those of Dai-kenchu-to, based on the increment of CGRP-IS levels in human plasma, may include not only the improvement of peristaltic contractions but also increments in intestinal blood flow, both of which are mediated by CGRP.
Substance P coexists with CGRP in the sensory afferent neurons of the gastrointestinal mucosa and is released with ACh in response to depolarizing stimulation in the enteric nervous system. 25) In the intestine, substance P controls motility and secretion. 26) Previous studies have shown that substance P neurons project into the myenteric plexus and circular muscle layer and may be involved in the regulation of the ascending contractile component of the peristaltic reflex. 27 ) Furthermore Schmidt et al. reported that administration of tachykinins/substance P to healthy volunteers increased intestinal mucosal blood flow. 28) Although whether substance P actually participates in the physiologic regulation of mucosal blood flow in the gastrointestinal tract is still not known, substance P may also be involved in regulation of the peristaltic reflex and of the mucosal blood flow in the intestine along with CGRP. In our results, Ninjin-to raised plasma substance P-IS levels after administration to healthy subjects. Ninjin-to may act in the gastrointestinal system and part of its action may be closely related to changes in substance P-IS levels in plasma.
In previous reports, Naito et al. assumed that Ninjin-to increases plasma somatostatin and motilin levels to improve gastrointestinal motor dysfunction and intracellular communication between somatostatin and motilin. 8) Somatostatin, a polypeptide widely distributed in the gastrointestinal tract, participates in the control of gut motility by exerting both inhibitory and stimulating influences. It is known that CGRP stimulates gastric somatostatin secretion and its actions are due to a direct effect on the gastric somatostatin-producing D-cells. 29) Somatostatin is also present in a small population of neurons that project within the myenteric plexus and appears to play a part in the sensory nervous system. Somatostatin neurons appear to act as facilitatory interneurons in intestinal peristalsis. 30) Motilin is a powerful inducer of motor activity in the stomach and intestine. It is reported that motilin-producing cells are innervated by local or intramural cholinergic neurons.
31) The previous reports and our results demonstrate that Ninjin-to stimulates CGRP, substance P, and somatostatin release from nerve endings and motilin release through muscarinic receptors on motilin cells in the enteric nervous system exert its pharmacologic activity.
The herbs contained in Ninjin-to may have an effect on neuropeptides. Ninjin-to has Zingiberis siccatum rhizoma as one of its ingredients, and this herb contains 6-gingerol and 6-shogaol as bioactive components, both of which have vanilloid structures. Capsaicin, the pungent ingredient in red peppers and a vanilloid receptor agonist, stimulates capsaicin-sensitive afferent neurons, which release CGRP and substance P from their nerve endings. [32] [33] [34] [35] It has been reported that 6-shogaol produces an increase in intestinal blood flow, and that the CGRP receptor antagonist, CGRP (8-37), completely abolishes Ginger rhizome and 6-shogaol-induced hyperemia. 24) Naito et al. also reported that plasma CGRP and substance P levels significantly increased after administration of Zingiberis rhizoma extract to healthy subjects. 36) Therefore these results suggest that 6-gingerol and 6-shogaol are the predominant ingredients to stimulate to CGRP and substance P release from nerve endings.
We conclude that Ninjin-to may improve gastrointestinal motility and mucosal blood flow by significantly increasing CGRP and substance P-IS levels in plasma. Although further studies are needed to elucidate the mechanism, our findings indicate that Ninjin-to is closely related to changes in CGRP-IS and substance P-IS levels in plasma and it may be useful for the treatment of postoperative ileus.
